GreatWall Fund logo

GreatWall Fund

Asia, Guangdong, China, Shenzhen

Description

GreatWall Fund is an investment firm.

Investor Profile

GreatWall Fund has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series C, Seed rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Medical, Pharmaceutical, Health Care.

Stage Focus

  • Series A (33%)
  • Series C (33%)
  • Seed (33%)

Country Focus

  • China (100%)

Industry Focus

  • Medical
  • Pharmaceutical
  • Health Care
  • Hospital
  • Wellness
  • Biotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does GreatWall Fund frequently co-invest with?

China Industrial Asset Management
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CITIC Securities
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Advantech Capital
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
China Merchants Health
Asia, Hunan, China, Nanshan
Co-Investments: 1
CD Capital
Asia, Zhejiang, China, Ningbo
Co-Investments: 1
Dalton Venture
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Ares Management
North America, Illinois, United States, Chicago
Co-Investments: 1
CMB International Capital Corporation
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Co-Investments: 1
China Reform Fund Management
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by GreatWall Fund?

Wepure

Guangzhou, Guangdong, China

Wepure develops, manufactures, and distributes nano-microspheres made of silica gel and resin.

Advanced MaterialsManufacturing
Series BJan 13, 2026
Addygene

Guangzhou, Guangdong, China

Addy Gene is a gene editing technology firm that specializes in CRISPR/Cas research, development, services, and industrialization.

MedicalPharmaceutical
SeedAug 5, 2024
Amount Raised: $1,404,258
Stemirna

Beijing, Beijing, China

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.

BiotechnologyMedicalPharmaceutical
Series CJun 3, 2021
Amount Raised: $187,388,738
Wellem

Shanghai, Shanghai, China

Wellem is an operator of pediatric clinic franchise.

Health CareHospitalWellness
Series AJan 1, 2017

Find More Investors Like GreatWall Fund

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

GreatWall Fund | Pipeseed